Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. We evaluated the proinflammatory IL-6 cytokine and JAK-STAT signaling pathway related genes in circulating CD34+ cells of MPNs. Regarding lab...
Saved in:
Main Authors: | Vladan P. Čokić (Author), Olivera Mitrović-Ajtić (Author), Bojana B. Beleslin-Čokić (Author), Dragana Marković (Author), Marijana Buač (Author), Miloš Diklić (Author), Nada Kraguljac-Kurtović (Author), Svetozar Damjanović (Author), Pavle Milenković (Author), Mirjana Gotić (Author), Puri K. Raj (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
by: Sylvie Hermouet, et al.
Published: (2015) -
Differential Antivasoconstrictor Effects of Levcromakalim and Rilmakalim on the Isolated Human Mammary Artery and Saphenous Vein
by: Aleksandra Novaković, et al.
Published: (2003) -
Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019) -
The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Annette H. Schmitt-Graeff, et al.
Published: (2015) -
Myeloproliferative Neoplasms: Fatigue, depression & hemoglobi
by: Marina Stal
Published: (2019)